Hybrid Conferencee

International Conference on Hematology and Molecular Biology (ICHMB - 26)

6th - 7th October 2026 | Abu Dhabi, UAE

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Abu Dhabi. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Abu Dhabi event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Abu Dhabi conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Abu Dhabi, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Abu Dhabi."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Hematological Genetic Studies

This track focuses on the latest genetic research in hematology, emphasizing the role of genetic variations in blood disorders. Participants will explore how these studies contribute to the understanding of disease mechanisms and patient outcomes.

Track 02

Biomarker Discovery in Hematological Disorders

This session will highlight innovative approaches to biomarker discovery for various hematological conditions. Discussions will center on the implications of these biomarkers for early diagnosis and personalized treatment strategies.

Track 03

Translational Research in Hematology

This track aims to bridge the gap between laboratory findings and clinical applications in hematology. Researchers will present their work on translating basic science discoveries into effective therapeutic interventions.

Track 04

Clinical Research Methodologies in Hematology

This session will cover cutting-edge clinical research methodologies employed in hematology. Emphasis will be placed on study design, data analysis, and the ethical considerations of conducting research in this field.

Track 05

Innovative Laboratory Techniques in Hematology

Participants will explore novel laboratory techniques that enhance the diagnosis and treatment of hematological diseases. This track will showcase advancements in imaging, molecular diagnostics, and cell-based assays.

Track 06

Therapeutic Strategies for Blood Disorders

This session will focus on emerging therapeutic strategies for the treatment of various blood disorders, including novel drug development and gene therapy. Discussions will include the challenges and successes of implementing these strategies in clinical practice.

Track 07

Mechanisms of Hematological Diseases

This track will delve into the underlying mechanisms of hematological diseases, including genetic, environmental, and immunological factors. Researchers will present their findings on how these mechanisms influence disease progression and treatment response.

Track 08

Patient Care and Management in Hematology

This session will address best practices in patient care and management for individuals with hematological disorders. Topics will include multidisciplinary approaches, patient education, and the role of supportive care in treatment outcomes.

Track 09

Emerging Trends in Hematology Research

Participants will discuss emerging trends and future directions in hematology research, including the integration of artificial intelligence and big data analytics. This track aims to foster collaboration and innovation in the field.

Track 10

Ethical Considerations in Hematology Research

This session will explore the ethical challenges faced by researchers in the field of hematology. Discussions will include informed consent, data privacy, and the implications of genetic research on patient populations.

Track 11

Global Perspectives on Hematology and Patient Care

This track will provide a platform for sharing global perspectives on hematology practices and patient care. Participants will discuss disparities in access to care, treatment options, and the impact of cultural factors on patient outcomes.